12h
Zacks.com on MSNCRISPR Therapeutics Stock Before Q4 Earnings: To Buy or Not to Buy?CRISPR Therapeutics CRSP is expected to report fourth-quarter and full-year 2024 earnings later this month. The Zacks ...
Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...
Today, we have a look at the White House's reported plans to make major cuts across federal health agencies. Also, Eli Lilly is expanding the ...
Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...
For the second time in less than a year, doctors at Massachusetts General Hospital have transplanted a genetically-edited pig ...
The second person ever has received a transplant with a genetically modified pig kidney.
Racial disparities in mortality are increasing. This article explores how the production of DNA-edited ethnically diverse ...
At number 7 on the list is our most recent interview with Austin-based director Jeff Nichols. This isn’t the first time we’ve ...
13h
AZoLifeSciences on MSNNew CRISPR Tool Reveals Key Lymphoma GenesThis study presents an optimized CRISPR-Cas12a system for large-scale genetic screening, revealing critical genes involved in lymphoma development and therapy.
On Friday, doctors at Massachusetts General Hospital announced that a 66-year-old New Hampshire man had successfully received ...
Genesis announced that it has completed its second successful human transplant with a genetically engineered pig kidney, with ...
For the second time in less than a year, doctors at Massachusetts General Hospital have transplanted a genetically-edited pig ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results